Related Laws Explorer

Requires all food service permit holders in Michigan to provide written physical or electronic notification of any FDA-designated major food allergens used in unpackaged food items served or sold to consumers.

Requires private health insurers to provide epinephrine products without deductibles, copayments, or coinsurance.

Michigan House Bill 5402 (introduced Dec. 18, 2025), referred to the Regulatory Reform Committee, would amend the Michigan Food Law to require food service establishments to provide written, item-level major food allergen notices to consumers for unpackaged food items.

Would require food service establishments to provide written notification (on menus, placards, or electronically) of the presence of major food allergens in unpackaged food items.

Authorizes school districts to acquire and maintain a supply of epinephrine auto-injectors for use by trained personnel in emergency anaphylaxis situations.

Allows school districts to acquire and maintain a supply of epinephrine auto-injectors and provides immunity for trained staff administering them.

Massachusetts Stock Epinephrine Bill

This pending bill would require all schools to maintain a stock supply of non-patient specific epinephrine auto-injectors. It mandates that the Department of Public Health create regulations for storage in unlocked locations and staff training.

Epinephrine Delivery Systems Update

A pending bill that updates existing school health statutes to replace the term 'epinephrine auto-injectors' with 'epinephrine delivery systems.' This change is intended to allow schools to stock newer, needle-free epinephrine options such as nasal sprays.

School Epinephrine Administration Expansion Bill

Legislative bill to explicitly codify into the General Laws the authority for school districts and non-public schools to register to train unlicensed school personnel to administer epinephrine auto-injectors during school hours and school-sponsored events when a nurse is not immediately available.

Elijah's Law

Establishes 'Elijah's Law' for Missouri, requiring licensed child care facilities to adopt allergy prevention and emergency response policies, and explicitly adds child care facilities to authorized entities allowed to acquire and stock epinephrine auto-injectors.

Needle Free Epinephrine Bill

Proposed legislation to update existing statutes to explicitly allow the use of epinephrine nasal sprays in addition to auto-injectors in school settings.

Proposes authorizing child care facilities to maintain a stock supply of epinephrine and train designated personnel to administer it in emergencies.

Safe Step Act

Requires group health plans to establish a transparent exceptions process (24-72 hours) for step therapy protocols, allowing doctors to override insurer fail-first requirements when medically necessary.

SponsorSen. Tammy Baldwin (D-WI), Rep. Lucy McBath (D-GA) (Bipartisan)

HELP Copays Act

Bans copay accumulator adjustment policies that prevent manufacturer copay assistance from counting toward patient deductibles and out-of-pocket maximums.

SponsorSen. Roger Marshall (R-KS) (Bipartisan)

Chronic Disease Flexible Coverage Act

Expands coverage options for individuals with chronic diseases including asthma by allowing states to offer targeted chronic disease coverage plans outside of traditional open enrollment.

New York Asthma Inhaler Coverage Act (S.3100A)

S.3100A expands New York insurance coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children. New Yorkers with asthma can face large financial barriers to drugs that hinder optimal treatment; high out-of-pocket costs hinder adherence, threaten patient health, and exacerbate health disparities. The bill passed the Senate 59-2 on March 17, 2025 and was reported and committed to the Finance Committee on May 12, 2026.

Federal bill to cap the cost of life-saving epinephrine injectors by establishing cost-sharing requirements under group health plans and health insurance coverage.

Requires private health insurers to provide epinephrine products without deductibles, copayments, or coinsurance.